Margin-Controlled, Staged Surgical Excision in the Treatment of High-Risk Basal Cell Carcinomas of the Head and Neck Region


Ucar A. N. D. , DURMUŞ KOCAASLAN F. N. , SALMAN A., Demirkesen C. , Bayram F. E. , Bayramicli M.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, cilt.23, ss.258-264, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 23 Konu: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1177/1203475418820868
  • Dergi Adı: JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
  • Sayfa Sayıları: ss.258-264

Özet

Background: The most common skin cancer is basal cell carcinoma (BCC), and the gold-standard treatment for high-risk tumours is Mohs surgery. However, alternative methods are needed for high-risk tumours in countries where the performance rate of Mohs surgery is low. Objectives: The objective of this article is to investigate the feasibility, efficacy, and safety of margin-controlled, staged surgical excision (MCSSE) in high-risk tumours as a possible treatment alternative. Methods: A retrospective cohort study, including patients diagnosed with high-risk BCC in the head and neck region and treated with MCSSE between 2003 and 2010, was conducted. Results: During the study period 50 tumours in 47 patients were treated, with low adverse event rates and high patient satisfaction rates. Of the 50 tumours, 1 recurred at the 12-month follow-up. Conclusions: Despite the small sample size and relatively short follow-up period, the present study shows that MCSSE might be a feasible alternative for the treatment of high-risk BCCs in institutions where Mohs surgery is not performed. Future studies on long-term recurrence rates are needed.